[HTML][HTML] Combination of antiplatelet and anticoagulant therapy, component network meta-analysis of randomized controlled trials

L Szapáry, D Tornyos, P Kupó, R Lukács… - Frontiers in …, 2022 - frontiersin.org
Background Despite numerous randomized clinical trials (RCT), data regarding the efficacy
of antiplatelet and anticoagulant combinations are still conflicting. We aimed to analyze …

Combination of antiplatelet and anticoagulant therapy, component network meta-analysis of randomized controlled trials

L Szapáry, D Tornyos, P Kupó… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Despite numerous randomized clinical trials (RCT), data regarding the efficacy
of antiplatelet and anticoagulant combinations are still conflicting. We aimed to analyze …

[HTML][HTML] Combination of antiplatelet and anticoagulant therapy, component network meta-analysis of randomized controlled trials

L Szapáry, D Tornyos, P Kupó, R Lukács… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Background Despite numerous randomized clinical trials (RCT), data regarding the efficacy
of antiplatelet and anticoagulant combinations are still conflicting. We aimed to analyze …

Combination of antiplatelet and anticoagulant therapy, component network meta-analysis of randomized controlled trials.

L Szapáry, D Tornyos, P Kupó, R Lukács… - Frontiers in …, 2022 - europepmc.org
Background Despite numerous randomized clinical trials (RCT), data regarding the efficacy
of antiplatelet and anticoagulant combinations are still conflicting. We aimed to analyze …

Combination of antiplatelet and anticoagulant therapy, component network meta-analysis of randomized controlled trials

L Szapáry, D Tornyos, P Kupó, R Lukács… - 2022 - europepmc.org
Background Despite numerous randomized clinical trials (RCT), data regarding the efficacy
of antiplatelet and anticoagulant combinations are still conflicting. We aimed to analyze …